In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailExact Sciences' shares pop on positive Cologuard trial resultsKevin Conroy, Exact Sciences CEO, joins 'Fast Money' to discuss Exact Sciences latest trial results for its colo-rectal cancer tests, Cologuard.
Persons:
Kevin Conroy
Organizations:
Sciences